LABO Eyesp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 3 financial statements were filed late (the longest delay 191 days for 2022).
- 2025not filed
- 202415/10/2025
- 202320/09/2024
- 202222/01/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the following is required to make declarations on behalf of the company: 1. if no Vice-President of the Management Board has been appointed – joint action by the President of the Management Board jointly with a member of the management board, or by the President of the Management Board jointly with a commercial proxy; 2. if a Vice-President of the Management Board has been appointed – joint action by the President of the Management Board jointly with the Vice-President of the Management Board, or by the Vice-President of the Management Board jointly with a member of the management board, or by the Vice-President of the Management Board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 30 | $405.19 | 30% | |
Łukasz Polakage 52 | 70 | $945.43 | 70% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2022-02-05 to 2026-09-29.
Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)
Debt
1 closed proceeding recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Dec 31, 2025 | Discontinued enforcement proceedings | Closed |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 24, 2022 | Aid for SME access to finance — aid for start-ups | $179.5K$179,453 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Laboratorium Badawcze Sorbolabsp. z o.o. | $1,593,152.63 | sorbolab.pl | ||
| Centrum Alergologiisp. z o.o. | $812,503.07 | centrumalergologii.pl | ||
| Reumedikasp. z o.o. | $323,427.61 | reumedika.pl | ||
| Wielkopolskie Centrum Medycyny Podróżysp. z o.o. | $175,243.92 | medtrop.pl | ||
| Green Cenergysp. z o.o. | $47,243.84 | greencenergy.pl | ||
| EmpekoS.A. | $13,339.66 | empeko.pl | ||
| Biuro Studiów Inżynierskich Resolv3d Poznańsp. z o.o. | $3,223.34 | resolv3d.pl | ||
| Klause&StaschS.A. | $2,988.76 | klausestasch.kmpsa.net.pl | ||
| Optiliosp. z o.o. | $2,789.21 | optil.io | ||
| Empyriosp. z o.o. | $753.70 | empyrio.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-02-27 | Business suspended | |
| 2022-01-25 | Entered in the register |
FAQ
Last updated: 2026-04-10